COR - Cencora Recent Insider Activity | Benzinga
Revealing a significant insider sell on March 20, Elizabeth S Campbell, Executive Vice President at Cencora (NYSE:COR), as per the latest SEC filing.
What Happened: According to a Form 4 filing with the U.S. Securities and Exchange Commission on Wednesday, Campbell sold 6,977 shares of Cencora. The total transaction value is $1,661,363.
In the Thursday's morning session, Cencora's shares are currently trading at $242.41, experiencing a up of 0.22%.
Discovering Cencora: A Closer Look
Cencora is one of three domestic leading pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and Cardinal Health constitute over 90% of the U.S. pharmaceutical wholesale industry. Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health). Cencora expanded its international presence in 2021 by purchasing Alliance Healthcare, one of the leading drug wholesalers in Europe.
Cencora: Delving into Financials
Positive Revenue Trend: Examining Cencora's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 14.97% as of 31 December, 2023, ...